12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 500 Internal Server Error [1] => Date: Sat, 30 Nov 2024 04:50:44 GMT [2] => Content-Type: text/html; charset=UTF-8 [3] => Connection: close [4] => X-Powered-By: PHP/7.4.33 [5] => Cache-Control: no-cache, private [6] => X-Frame-Options: SAMEORIGIN [7] => X-XSS-Protection: 1; mode=block [8] => X-Content-Type-Options: nosniff [9] => Referrer-Policy: no-referrer-when-downgrade [10] => CF-Cache-Status: DYNAMIC [11] => Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=Y1KCClsqaxmg994YwoGagRAG7Ox5KfY1ezWDdsGF7BKJDK5qVTv9Kr1BWqwB1FuD8RO%2BGMRD9WaDY%2F9NXE7IpMd7%2BTeNMFU6NOhcv1Ia6piYbN7cOIe2CEM0rw6%2FRrumZ6s%3D"}],"group":"cf-nel","max_age":604800} [12] => NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} [13] => Server: cloudflare [14] => CF-RAY: 8ea837e2689f8409-LAX [15] => alt-svc: h3=":443"; ma=86400 [16] => server-timing: cfL4;desc="?proto=TCP&rtt=201131&min_rtt=201108&rtt_var=56599&sent=5&recv=6&lost=0&retrans=0&sent_bytes=2998&recv_bytes=756&delivery_rate=14400&cwnd=33&unsent_bytes=0&cid=52c3ff64bfce5bc3&ts=677&x=0" ) 789

针对新加坡科学局宣布召回3种含有超标致癌物质的药物二甲双胍（metformin），我国卫生部周四发文告强调，我国并没批准发售这3种药物。

这3种药物包括Glucient XR Tablet 500mg、Meijumet Prolonged Release Tablet 750mg，以及Meijumet Prolonged Release Tablet 1000mg；有关药物是控制血糖的药物。

卫生总监拿督诺希山周四在文告中指出，卫生部对国家药品监管局（NPRA）注册的药物进行审查后发现，美国药物管制局共检验101项药物含有二甲双胍成份，然而只有获得注册的药物才获准在我国发售。

文告指，NDMA是亚硝胺基的杂质之一，通常含量较低。“根据国际癌症研究机构（IARC）显示，长期服用NDMA将增加患癌风险。”

“二甲双胍是一种治疗糖尿病以控制血糖的药物，平时可从医生或药剂师处获取。”

无论如何，国家药品监管局将继续监视市面上的药物，确保药物的质量、安全和有效性，并随时提醒民众。